Immunogenicity and risks associated with impaired immune responses following SARS-CoV-2 vaccination and booster in hematologic malignancy patients: an updated meta-analysis

SARS-CoV-2 Vaccine Development: An Overview and Perspectives

Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naive residents of long-term care facilities: an observational cohort study - The Lancet Healthy Longevity

Neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 and wild-type virus in patients with inflammatory bowel disease following three doses of COVID-19 vaccine (VIP): a prospective, multicentre, cohort study - eClinicalMedicine

The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study - The Lancet Rheumatology

Biomedicines, Free Full-Text

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

COVID-19 in patients with hematologic malignancy - ScienceDirect

Immunology and Technology of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines

Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis

COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety

Cancers, Free Full-Text

Capturing adaptive immunity against SARS-CoV-2 in patients with cancer

Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 ( SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis - ScienceDirect

Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Immunogenicity among Chimeric Antigen Receptor T Cell Therapy Recipients - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy

A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19: Molecular Therapy